Literature DB >> 8676097

Distribution and molecular forms of urotensin II and its role in cardiovascular regulation in vertebrates.

J M Conlon1, K Yano, D Waugh, N Hazon.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1996        PMID： 8676097

Source DB:  PubMed          Journal:  J Exp Zool        ISSN： 0022-104X


× No keyword cloud information.
  17 in total

1.  Differential vasoconstrictor activity of human urotensin-II in vascular tissue isolated from the rat, mouse, dog, pig, marmoset and cynomolgus monkey.

Authors:  S A Douglas; A C Sulpizio; V Piercy; H M Sarau; R S Ames; N V Aiyar; E H Ohlstein; R N Willette
Journal:  Br J Pharmacol       Date:  2000-12       Impact factor: 8.739

2.  Urotensin II acutely increases myocardial length and distensibility: potential implications for diastolic function and ventricular remodeling.

Authors:  Ana Patrícia Fontes-Sousa; Carmen Brás-Silva; Ana Luísa Pires; Daniela Monteiro-Sousa; Adelino F Leite-Moreira
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2007-08-14       Impact factor: 3.000

3.  Cloning of the cDNA encoding the urotensin II precursor in frog and human reveals intense expression of the urotensin II gene in motoneurons of the spinal cord.

Authors:  Y Coulouarn; I Lihrmann; S Jegou; Y Anouar; H Tostivint; J C Beauvillain; J M Conlon; H A Bern; H Vaudry
Journal:  Proc Natl Acad Sci U S A       Date:  1998-12-22       Impact factor: 11.205

Review 4.  The role of urotensin II in cardiovascular and renal physiology and diseases.

Authors:  Yi-Chun Zhu; Yi-Zhun Zhu; Philip Keith Moore
Journal:  Br J Pharmacol       Date:  2006-06-19       Impact factor: 8.739

5.  Human urotensin-II is a potent spasmogen of primate airway smooth muscle.

Authors:  D W Hay; M A Luttmann; S A Douglas
Journal:  Br J Pharmacol       Date:  2000-09       Impact factor: 8.739

6.  Deletion of the UT receptor gene results in the selective loss of urotensin-II contractile activity in aortae isolated from UT receptor knockout mice.

Authors:  David J Behm; Stephen M Harrison; Zhaohui Ao; Kristeen Maniscalco; Susan J Pickering; Evelyn V Grau; Tina N Woods; Robert W Coatney; Christopher P A Doe; Robert N Willette; Douglas G Johns; Stephen A Douglas
Journal:  Br J Pharmacol       Date:  2003-05       Impact factor: 8.739

7.  Hemodynamic effects of chronic urotensin II administration in animals with and without aorto-caval fistula.

Authors:  Gregory S Harris; Robert M Lust; Laxmansa C Katwa
Journal:  Peptides       Date:  2007-05-06       Impact factor: 3.750

8.  Comparative genomics provides evidence for close evolutionary relationships between the urotensin II and somatostatin gene families.

Authors:  Hervé Tostivint; Lucille Joly; Isabelle Lihrmann; Caroline Parmentier; Alexis Lebon; Mireille Morisson; André Calas; Marc Ekker; Hubert Vaudry
Journal:  Proc Natl Acad Sci U S A       Date:  2006-02-07       Impact factor: 11.205

9.  Effects of urotensin II and its specific receptor antagonist urantide on rat vascular smooth muscle cells.

Authors:  Juan Zhao; Shu-Feng Zhang; Yan Shi; Li-Qun Ren
Journal:  Bosn J Basic Med Sci       Date:  2013-05       Impact factor: 3.363

10.  Identification and pharmacological characterization of native, functional human urotensin-II receptors in rhabdomyosarcoma cell lines.

Authors:  Stephen A Douglas; Diane Naselsky; Zhaohui Ao; Jyoti Disa; Christopher L Herold; Frank Lynch; Nambi V Aiyar
Journal:  Br J Pharmacol       Date:  2004-06-21       Impact factor: 8.739
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.